Healthcare - Biotechnology - NASDAQ - US
$ 6.86
-5.38 %
$ 143 M
Market Cap
-1.2
P/E
CASH FLOW STATEMENT
-90.9 M
OPERATING CASH FLOW
96.9 M
INVESTING CASH FLOW
69 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Adverum Biotechnologies, Inc.
| Net Income | -117 M |
| Depreciation & Amortization | 5.64 M |
| Capital Expenditures | -808 K |
| Stock-Based Compensation | 17.6 M |
| Change in Working Capital | -8.32 M |
| Others | 3.42 M |
| Free Cash Flow | -91.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (117.2) | (154.5) | (145.5) | (117.5) | (64.5) | (72.6) | (56.1) | (113.7) | (47.5) | (25.4) | (5.3) | (1.8) |
| Depreciation & Amortization | 5.6 | 6.5 | 4.6 | 4.2 | 1.6 | 1.8 | 2.1 | 1.6 | 0.8 | 0.2 | 26 K | 1 K |
| Deferred Income Tax | 0 | 0 | 3.8 | 0.9 | (1.3) | (1.2) | 0.6 | 60.7 | 0.8 | 1.0 | 1.7 | 19 K |
| Stock Based Compensation | 17.6 | 20.1 | 25.2 | 20.4 | 9.9 | 13.4 | 8.7 | 11.4 | 11.5 | 8.6 | 0.5 | 76 K |
| Other Operating Activities | 11.4 | 51 K | 25 K | 75 K | 58 K | 6.4 | 70 K | 8 K | 0.2 | 18 K | 0.9 | 16 K |
| Change in Working Capital | (8.3) | 19.9 | 4.1 | 12.7 | 5.1 | (1.6) | (0.8) | 1.6 | (1.2) | 10.0 | 70 K | 0.5 |
| Cash From Operations | (90.9) | (108.1) | (107.8) | (79.3) | (49.2) | (54.0) | (45.4) | (38.4) | (35.3) | (5.6) | (2.2) | (1.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.8) | (11.8) | (15.1) | (11.8) | (19.2) | (0.8) | (1.0) | (2.4) | (3.0) | (0.9) | 91 K | 3 K |
| Other Items | 97.7 | 153.5 | 93.8 | (268.3) | (48.8) | 70.3 | (121.2) | 41.2 | (38.6) | 0 | 0 | 0 |
| Cash From Investing Activities | 96.9 | 141.7 | 78.7 | (280.2) | (68.1) | 69.4 | (122.2) | 38.8 | (41.6) | (0.9) | 91 K | 3 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (4.0) | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.2) | 61 K | (0.1) | (0.2) | 0 | 0 | 0 | 2.0 | 1.5 | 0.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.4) | 0.6 | 1.0 | 11.7 | 2.4 | 63 K | 0.2 | 0.6 | 94 K | 47.0 | 1.0 | 0 |
| Cash From Financing Activities | 69 K | 0.6 | 2.4 | 356.0 | 28.2 | 69.9 | 16.7 | 0.6 | 138.9 | 165.4 | 2.5 | 0.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 6.0 | 34.2 | (26.7) | (3.5) | (89.1) | 85.4 | (151.7) | 0.8 | 61.9 | 158.8 | 0.2 | (0.8) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (91.7) | (119.9) | (123.0) | (91.1) | (68.4) | (54.8) | (46.4) | (40.8) | (38.3) | (6.6) | (2.3) | (1.3) |